using engineered t-cells to suppress acute gvhd and leukemia relapse after allosct
Published 1 year ago • 141 plays • Length 2:05Download video MP4
Download video MP3
Similar videos
-
4:21
engineered t-cells to prevent gvhd in leukemia
-
0:58
management strategies for acute and chronic gvhd following allosct
-
3:30
targeting t-cell, b-cell & apc activation to treat chronic gvhd
-
3:39
hsct with t-cell add-back of rivogenlecleucel in acute leukemia
-
2:49
identifying novel antigens for tcr t-cell therapy
-
4:26
targeted t cell killing
-
1:56
avsu htm | gce healthcare
-
3:28
tcr-mimic antibody platform_biocytogen
-
1:23
t-cell metabolism: a novel therapeutic avenue for gvhd
-
1:12
managing gvhd in patients undergoing sct
-
2:48
virus-specific t cells - effectiveness, safety profile and use
-
4:24
investigating production failure and out-of-specification production of car t-cell therapeutics
-
3:54
impact of donor kinship on outcome of haplohct with ptcy in acute leukemias
-
1:01
engineering molecular on- and off-switches for controlling car t-cells
-
1:26
next-generation diagnostic and prognostic approaches in multiple myeloma
-
1:39
the role of myeloid cells in car-t cell therapy
-
2:11
exploring strategies to mitigate t-cell exhaustion: treatment-free intervals & small molecules
-
0:47
novel agents being explored for the treatment of immune-mediated ttp
-
0:34
t-cell engineering advances at icle 2022
-
1:26
cellular therapy: a key part of ebmt 2017
-
4:06
treating covid-19 with modified t-cells for immunocompromised patients
-
3:02
the interplay between t-all cells & tecs and the role of tecs in disease progression